[The differential use of 99mTc-DTPA and 99mTc-MAG3 in the aftercare of kidney transplant patients].
Kotzerke
J
J
Abteilung Nuklearmedizin und spezielle Biophysik, Medizinische Hochschule, Hannover.
Burchert
W
W
Ringe
B
B
Hundeshagen
H
H
D000359:Aftercare; D003937:Diagnosis, Differential; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides; D015609:Organotechnetium Compounds; D004369:Pentetic Acid; D011877:Radionuclide Imaging; D013530:Surgical Wound Infection / Q000000981:diagnostic imaging; D017263:Technetium Tc 99m Mertiatide; D016284:Technetium Tc 99m Pentetate
D009842:Oligopeptides; D015609:Organotechnetium Compounds; D017263:Technetium Tc 99m Mertiatide; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate
Differenzierter Einsatz von 99mTc-DTPA und 99mTc-MAG3 in der Nachsorge nierentransplantierter Patienten.